Clinical Trial Update: TACE Using Idarubicin Versus Doxorubicin Chemoemulsion in Patients with Hepatocellular Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial comparing transarterial chemoembolization with idarubicin versus doxorubicin emulsion in hepatocellular carcinoma is currently recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Doxorubicin (doxorubicin)
• Idarubicin (idarubicin)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Hepatocellular Carcinoma, Liver Cancer | Phase 2 | Status: RECRUITING